Regulatory-required post-marketing database studies in Japan could be leveraged to assess important potential risks as well as identified risks. - Yamazaki H; Nakajo K; Hirose N; Yan L; Lee SY; Zhang Y; Qiu H; Ishiguro C (Frontiers in pharmacology, 2025)